Literature DB >> 1391934

Progress in understanding the pathogenesis of the anemia of chronic disease.

R T Means1, S B Krantz.   

Abstract

Improved understanding of the inflammatory response and the identification and characterization of the specific cytokines involved, as well as improved understanding of erythropoiesis, and the availability of recombinant human growth factors such as EPO, have greatly enhanced our appreciation of the pathogenesis of ACD by allowing development of a number of informative models for studying this syndrome. It appears that a variety of cytokines are involved in all aspects of the pathogenesis of ACD, from the inhibition of erythroid progenitors and EPO production to impairment of iron release. A schematic of the contributions of some of these cytokines to the development of ACD is shown in Fig 6. The exact biochemical mechanisms by which these effects occur is still to be determined. The progress outlined in this report has allowed us to develop a more precise understanding of the pathogenesis of this common and important clinical syndrome. In 1983, Hansen subtitled a review of ACD "A Bag of Unsolved Questions." Although this description is still accurate, our understanding of ACD has now developed to the point where we can offer a more defined subtitle: "A Bag of Cytokines."

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391934

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  89 in total

Review 1.  Recent advances in haematology.

Authors:  D Provan; D F O'Shaughnessy
Journal:  BMJ       Date:  1999-04-10

2.  Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study.

Authors:  Antonio Macciò; Clelia Madeddu; Giulia Gramignano; Carlo Mulas; Eleonora Sanna; Giovanni Mantovani
Journal:  Oncologist       Date:  2010-07-20

3.  Clinical analysis of primary Sjögren's syndrome complicating anemia.

Authors:  Jing-Guo Zhou; Yu-Feng Qing; Li Jiang; Qi-Bin Yang; Wen-Feng Luo
Journal:  Clin Rheumatol       Date:  2010-02-20       Impact factor: 2.980

4.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin.

Authors:  M Voulgarelis; S I Kokori; J P Ioannidis; A G Tzioufas; D Kyriaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

5.  Single measurement of hemoglobin predicts outcome of HCC patients.

Authors:  Fabian Finkelmeier; Dominik Bettinger; Verena Köberle; Michael Schultheiß; Stefan Zeuzem; Bernd Kronenberger; Albrecht Piiper; Oliver Waidmann
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

6.  L-arginine administration reverses anemia associated with renal disease.

Authors:  Takahisa Tarumoto; Shigehiko Imagawa; Makoto Kobayashi; Aki Hirayama; Keiya Ozawa; Toshiro Nagasawa
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

7.  The possible role of early post-transplant inflammation in later anemia in kidney transplant recipients.

Authors:  Goran Imamović; Enver Zerem; Safet Omerović; Enes Osmanović; Emir Hodzić
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

Review 8.  Identification and treatment of anaemia in older patients.

Authors:  P T Murphy; R M Hutchinson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 9.  Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.

Authors:  S Giannouli; M Voulgarelis; P D Ziakas; A G Tzioufas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

10.  Cisplatin-associated anemia: an erythropoietin deficiency syndrome.

Authors:  P A Wood; W J Hrushesky
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.